News on Hepatitis continually updated from thousands of sources around the net.
4 hrs ago | Fox 23
Dec. 9, 2013 -- Experts call two new drugs for hepatitis C ''game changers" that they expect will dramatically improve treatment for many of the 3 million Americans with a chronic infection.
Should sexual orientation be a protected class (like race and gender) to prevent discrimination?
Should nudity be off-limits on prime-time TV?
8 hrs ago | EDGE
A discussion about the risk of transmitting or contracting HIV without mentioning Hepatitis C is like talking about Clyde Barrow without Bonnie Parker.
9 hrs ago | Kansas City InfoZine
Sovaldi is the second drug approved by the FDA in the past two weeks to treat chronic HCV infection.
13 hrs ago | Yahoo!
Health officials in the United States have approved a highly anticipated hepatitis C drug that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.
The most recent issue of the Alimentary Pharmacology & Therapeutics compares the effectiveness of the hepatitis C virus protease inhibitors boceprevir vs telaprevir in a large cohort in the USA.
KosAbility is a Sunday afternoon community series by volunteer diarists, as a gathering for people living with disabilities, who love someone with a disability, or who want to know more about the issues.
There are five kinds of hepatitis: A, B, C, D, and E. This condition is caused by inflammation of the liver and is commonly caused by a virus.
For the second time in two weeks, the FDA has approved a new drug for the treatment of hepatitis C. The new drugs, called Sovaldi and Olysio, promise to quickly cure a majority of patients with very few side effects.
Eric von Hofe is preparing the two-person company Antigen Express Inc. for a review of data from studies of a breast cancer vaccine.
What do Mickey Mantle, Evel Knievel, Naomi Judd, Pamela Anderson, Jim Nabors and Keith Richards have in common? They have all faced hepatitis C. And they are not the only ones; about 3.2 million Americans have chronic hepatitis C. It claims the lives of more people each year than HIV/AIDS and is the leading cause of liver transplants in the United ... (more)
AIDS Healthcare Foundation , the nation's largest HIV/AIDS nonprofit medical provider, expressed its profound outrage at Gilead Sciences over the price of Sovaldi, its new Hepatitis C drug, which was approved by the Food and Drug Administration on Friday.
New needles like those shown in 2004 photo are available at Tapestry Health's needle exchange program in Holyoke.
U.S. consumers increased their spending in October even though their wages and salaries barely increased, raising questions about how strong the economy will grow at the end of the year.
In clinical trials, the polymerase inhibitor, the first used in hepatitis C treatment, has shown a more than 90 percent success rate in curing the deadly virus that causes liver failure and cancer of the liver .
The U.S. Food and Drug Administration has approved Gilead Sciences' hotly anticipated Sovaldi , a once-daily oral nucleotide analog polymerase inhibitor to treat people with hepatitis C virus , including those coinfected with HIV and those who have liver cancer and are awaiting a transplant.
Sovaldi is the first drug that has been shown to safely and effectively treat certain types of hepatitis C infection without a need for interferon, the FDA said.